Q32 Bio, Inc. (QTTB)
9.25
+0.40
(+4.52%)
USD |
NASDAQ |
Nov 06, 16:00
9.25
0.00 (0.00%)
After-Hours: 20:00
Q32 Bio Total Long Term Debt (Quarterly) : 4.364M for Sept. 30, 2026
Total Long Term Debt (Quarterly) Chart
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 4.364M |
| June 30, 2026 | 4.561M |
| March 31, 2026 | 12.93M |
| December 31, 2025 | 14.65M |
| September 30, 2025 | 16.35M |
| June 30, 2025 | 18.05M |
| March 31, 2025 | 18.17M |
| December 31, 2024 | 18.29M |
| September 30, 2024 | 18.40M |
| June 30, 2024 | 18.50M |
| March 31, 2024 | 18.59M |
| December 31, 2023 | 50.30M |
| September 30, 2023 | 26.56M |
| June 30, 2023 | 27.02M |
| March 31, 2023 | 27.48M |
| December 31, 2022 | 27.92M |
| September 30, 2022 | 28.34M |
| June 30, 2022 | 23.59M |
| March 31, 2022 | 23.55M |
| Date | Value |
|---|---|
| December 31, 2021 | 23.69M |
| September 30, 2021 | 11.58M |
| June 30, 2021 | 12.05M |
| March 31, 2021 | 12.50M |
| December 31, 2020 | 12.94M |
| September 30, 2020 | 13.54M |
| June 30, 2020 | 14.19M |
| March 31, 2020 | 14.82M |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | 209.16M |
| Beam Therapeutics, Inc. | 228.23M |
| Prime Medicine, Inc. | 103.51M |
| Korsana Biosciences, Inc. | 0.984M |
| Prelude Therapeutics, Inc. | 14.87M |